Biological
MB-CART19.1
MB-CART19.1 is a biological therapy with 6 clinical trials. Currently 5 active trials ongoing.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
5(83%)
Phase Distribution
Ph phase_1
2
33%
Ph not_applicable
2
33%
Ph phase_2
2
33%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
5
trials recruiting
Total Trials
6
all time
Status Distribution
Active(5)
Other(1)
Detailed Status
Recruiting4
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
5
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (33.3%)
Phase 22 (33.3%)
N/A2 (33.3%)
Trials by Status
active_not_recruiting117%
unknown117%
recruiting467%
Recent Activity
5 active trials
Showing 5 of 6
active_not_recruitingphase_1
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
NCT03853616
recruitingnot_applicable
MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
NCT07371403
recruitingphase_2
Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL
NCT07271121
recruitingnot_applicable
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NCT06508775
recruitingphase_1
MB-CART19.1 in Refractory SLE
NCT06189157
Clinical Trials (6)
Showing 6 of 6 trials
NCT03853616Phase 1
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
NCT07371403Not Applicable
MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
NCT07271121Phase 2
Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL
NCT06508775Not Applicable
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NCT06189157Phase 1
MB-CART19.1 in Refractory SLE
NCT03321123Phase 2
MB-CART19.1 in Patients With R/R ALL
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6